QuidelOrtho Lowers FY2026 Adj EPS Guidance from $1.80-$2.00 to $0.65-$0.90 vs $1.84 Est; Lowers FY2026 Sales Guidance from $2.700B-$2.750B to $2.520B-$2.600B vs $2.705B Est

Benzinga Newsdesk www.benzinga.com Negative 94.8%

Neg 94.8% Neu 0% Pos 0%

QuidelOrtho (NASDAQ:QDEL) lowers FY2026 Adj EPS guidance from $1.80-$2.00 to $0.65-$0.90 vs $1.84 analyst estimate. Lowers FY2026 sales outlook from $2.700 billion-$2.750 billion to $2.520 billion-$2.600 billion vs $2.705 billion estimate.